Advanced Cell Technology, Inc. (ACTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advanced Cell Technology, Inc. (ACT) is a biotechnology company, specializes in regenerative medicine. The company participates in the development of cellular therapies for the treatment of diseases. Currently, ACT conducts the human embryonic stem cell (hESC)-based human clinical trials in the US and Europe. The two US trials use retinal pigment epithelial (RPE) cells derived from hESCs treats forms of macular degeneration, including Dry Age-Related Macular Degeneration (Dry AMD), the leading cause of blindness.

Advanced Cell Technology, Inc. Key Recent Developments

Mar 24, 2014: New Mesenchymal Stem Cell Population from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties
Jan 22, 2014: Advanced Cell Technology Announces Change in Management
Dec 18, 2013: Advanced Cell Technology Announces Release of New Edition of Definitive Resource in Tissue Engineering
Dec 12, 2013: Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Nov 12, 2013: Advanced Cell Technology Announces 2013 Third Quarter Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Advanced Cell Technology, Inc. (ACTC) - Financial and Strategic SWOT Analysis Review
Table of Contents

Section 1 - About the Company 5
Advanced Cell Technology, Inc. - Key Facts 5
Advanced Cell Technology, Inc. - Key Employees 6
Advanced Cell Technology, Inc. - Key Employee Biographies 7
Advanced Cell Technology, Inc. - Major Products and Services 8
Advanced Cell Technology, Inc. - Pharmaceutical Pipeline Products Data 9
Advanced Cell Technology, Inc., Pipeline Products by Therapy Area 9
Advanced Cell Technology, Inc., Pipeline Products by Development Phase 10
Advanced Cell Technology, Inc. - History 12
Advanced Cell Technology, Inc. - Company Statement 15
Advanced Cell Technology, Inc. - Locations And Subsidiaries 17
Head Office 17
Other Locations and Subsidiaries 17
Section 2 - Company Analysis 18
Advanced Cell Technology, Inc. - Business Description 18
Advanced Cell Technology, Inc. - SWOT Analysis 19
SWOT Analysis - Overview 19
Advanced Cell Technology, Inc. - Strengths 19
Strength - Focused Research Expertise 19
Strength - Patent Portfolio: Intellectual Property 19
Strength - Strategic Collaborative Agreements 19
Advanced Cell Technology, Inc. - Weaknesses 19
Weakness - Involvement in Legal Proceedings 19
Weakness - History of Losses 20
Advanced Cell Technology, Inc. - Opportunities 20
Opportunity - Rising Geriatric Population 20
Opportunity - Market Potential: Age-related Macular Degeneration 20
Opportunity - Potential Market: Cardiovascular/ Heart Failure 20
Advanced Cell Technology, Inc. - Threats 20
Threat - Dependence on Emerging Technologies 20
Threat - Uncertain RandD Outcomes 21
Threat - Increasing Competitive Pressures 21
Advanced Cell Technology, Inc. - Key Competitors 22
Section 3 - Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 - Company's Lifesciences Financial Deals and Alliances 28
Advanced Cell Technology, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 28
Advanced Cell Technology, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 29
Advanced Cell Technology, Inc., Recent Deals Summary 30
Section 5 - Company's Recent Developments 31
Advanced Cell Technology, Inc., Recent Developments 31
Mar 24, 2014: New Mesenchymal Stem Cell Population from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties 31
Jan 22, 2014: Advanced Cell Technology Announces Change in Management 31
Dec 18, 2013: Advanced Cell Technology Announces Release of New Edition of Definitive Resource in Tissue Engineering 32
Dec 12, 2013: Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development 32
Nov 12, 2013: Advanced Cell Technology Announces 2013 Third Quarter Results 33
Nov 11, 2013: Advanced Cell Technology to Host Conference Call to Discuss 2013 Third Quarter Results and Provide a Corporate Update on Tuesday, November 12th 34
Oct 18, 2013: Advanced Cell Technology to Webcast 2013 Annual Shareholders' Meeting on Tuesday, October 22nd 34
Sep 25, 2013: Advance Cell Technology to Present at 2013 Aegis Capital Healthcare Conference 34
Aug 12, 2013: Advanced Cell Technology Files Preliminary Proxy Statement with Securities and Exchange Commission 34
Aug 07, 2013: Advanced Cell Technology Announces Second Quarter 2013 Results 35
Section 6 - Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables

Advanced Cell Technology, Inc., Key Facts 5
Advanced Cell Technology, Inc., Key Employees 6
Advanced Cell Technology, Inc., Key Employee Biographies 7
Advanced Cell Technology, Inc., Major Products and Services 8
Advanced Cell Technology, Inc., Number of Pipeline Products by Therapy Area 9
Advanced Cell Technology, Inc., Number of Pipeline Products by Development Stage 10
Advanced Cell Technology, Inc., Pipeline Products By Therapy Area and Development Phase 11
Advanced Cell Technology, Inc., History 12
Advanced Cell Technology, Inc., Other Locations 17
Advanced Cell Technology, Inc., Subsidiaries 17
Advanced Cell Technology, Inc., Key Competitors 22
Advanced Cell Technology, Inc., Ratios based on current share price 23
Advanced Cell Technology, Inc., Annual Ratios 23
Advanced Cell Technology, Inc., Interim Ratios 26
Advanced Cell Technology, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 28
Advanced Cell Technology, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 29
Advanced Cell Technology, Inc., Recent Deals Summary 30
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39

List of Figures

Advanced Cell Technology, Inc., Pipeline Products by Therapy Area 9
Advanced Cell Technology, Inc., Pipeline Products by Development Phase 10
Advanced Cell Technology, Inc., Performance Chart (2009 - 2013) 25
Advanced Cell Technology, Inc., Ratio Charts 27
Advanced Cell Technology, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 28
Advanced Cell Technology, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 29

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.